Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.lauruslabs.com | |
Market Cap | 20,680.12 Cr. | |
Enterprise Value(EV) | 22,700.56 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 6.82 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 56.22 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 38.52 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 74.81 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 5.13 | Calculated using Price: 383.70 |
Dividend Yield | 0.52 | Period Ending 2023-03 |
No. of Shares Subscribed | 53.90 Cr. | 538,965,858 Shares |
FaceValue | 2 | |
About Laurus Labs Ltd. | ||
Laurus Labs offers broad and integrated portfolio of Active Pharma Ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services to cater to the needs of the global pharmaceutical industry. Their major focus areas include anti-retroviral, Hepatitis C and Oncology drugs. |
1 Day |
|
-1.24% |
1 Week |
|
+1.05% |
1 Month |
|
+4.00% |
3 Month |
|
-4.97% |
6 Month |
|
+10.44% |
1 Year |
|
-7.56% |
2 Year |
|
-22.96% |
5 Year |
|
+410.07% |
10 Year |
|
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 14.47 | 18.65 | 18.12 | 11.97 | 6.19 | 15.39 | 45.15 | 28.05 | 21.63 | |
Return on Capital Employed (%) | 13.74 | 16.35 | 16.52 | 13.68 | 8.22 | 14.14 | 39.82 | 25.97 | 22.97 | |
Return on Assets (%) | 4.31 | 6.61 | 8.05 | 6.04 | 3.00 | 7.34 | 20.87 | 13.09 | 10.89 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 722 | 857 | 1,330 | 1,483 | 1,558 | 1,770 | 2,598 | 3,351 | 4,038 | 4,030 | |
Non Curr. Liab. | 364 | 428 | 132 | 174 | 295 | 214 | 693 | 928 | 1,179 | 1,069 | |
Curr. Liab. | 802 | 884 | 1,121 | 1,307 | 1,424 | 1,692 | 2,457 | 2,681 | 2,432 | 2,945 | |
Minority Int. | 3 | 8 | 11 | 13 | |||||||
Equity & Liab. | 1,888 | 2,169 | 2,584 | 2,964 | 3,278 | 3,676 | 5,751 | 6,968 | 7,660 | 8,058 | |
Non Curr. Assets | 1,024 | 1,166 | 1,444 | 1,716 | 1,815 | 1,864 | 2,676 | 3,623 | 4,199 | 4,390 | |
Curr. Assets | 862 | 1,003 | 1,140 | 1,248 | 1,463 | 1,812 | 3,075 | 3,345 | 3,462 | 3,668 | |
Misc. Exp. not W/O | 2 | ||||||||||
Total Assets | 1,888 | 2,169 | 2,584 | 2,964 | 3,278 | 3,676 | 5,751 | 6,968 | 7,660 | 8,058 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 1,327 | 1,778 | 1,905 | 2,056 | 2,292 | 2,832 | 4,814 | 4,936 | 6,041 | 5,332 | |
Other Income | 34 | 4 | 33 | 29 | 16 | 6 | 24 | 15 | 6 | 9 | |
Total Income | 1,361 | 1,782 | 1,938 | 2,085 | 2,308 | 2,838 | 4,837 | 4,951 | 6,047 | 5,340 | |
Total Expenditure | -1,131 | -1,415 | -1,497 | -1,643 | -1,936 | -2,267 | -3,263 | -3,513 | -4,448 | -4,288 | |
PBIDT | 229 | 367 | 441 | 443 | 372 | 570 | 1,574 | 1,438 | 1,598 | 1,052 | |
Interest | -101 | -111 | -100 | -80 | -88 | -90 | -68 | -102 | -165 | -177 | |
Depreciation | -62 | -86 | -106 | -125 | -164 | -187 | -205 | -251 | -324 | -355 | |
Taxation | 2 | -35 | -44 | -70 | -26 | -38 | -317 | -251 | -312 | -141 | |
Exceptional Items | |||||||||||
PAT | 68 | 134 | 191 | 168 | 94 | 255 | 984 | 832 | 797 | 378 | |
Minority Interest | 0 | -5 | -3 | -4 | |||||||
Share Associate | 0 | 0 | -1 | 0 | -3 | -6 | |||||
Other Related Items | -6 | ||||||||||
Consolidated Net Profit | 68 | 134 | 190 | 168 | 94 | 255 | 984 | 828 | 785 | 368 | |
Adjusted EPS | 2 | 4 | 4 | 3 | 2 | 5 | 18 | 15 | 15 | 7 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 121 | -65 | 182 | 332 | 342 | 298 | 347 | 733 | 911 | 994 | |
Cash Fr. Inv. | -312 | -397 | -312 | -289 | -384 | -253 | -221 | -941 | -914 | -996 | |
Cash Fr. Finan. | 203 | 486 | 103 | -54 | 42 | -45 | -128 | 255 | 30 | -27 | |
Net Change | 12 | 24 | -27 | -10 | 1 | 0 | -1 | 47 | 27 | -29 | |
Cash & Cash Eqvt | 15 | 40 | 13 | 2 | 3 | 3 | 2 | 48 | 75 | 46 |
Fri, 08 Dec 2023
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS Allotment of ESOPs on December 08 2023 |
Fri, 24 Nov 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Plant visit at Visakhapatnam and management interaction on December 01 2023 |
Fri, 24 Nov 2023
Announcement under Regulation 30 (LODR)-Investor Presentation Investor PPT |
Fri, 08 Dec 2023 |
|
|
|
|
|